FOR IMMEDIATE RELEASE
DENVER – October 1, 2014
Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances. The LARIAT™ procedure utilizes the LARIAT™ Suture Delivery Device and non-invasive techniques to access the heart and close off a region of the heart known to cause blood clots that can lead to stroke as a consequence of atrial fibrillation.
“This is the first therapy we have had to offer patients who are at high risk of stroke but unable to take anticoagulants,” says Dr. Tom Svinarich, Rose Medical Center interventional electrophysiologist. “We can now prevent strokes in patients who are otherwise at high risk of bleeding on oral anticoagulants.”
The LARIAT™ procedure is performed by a team comprised of Rose electrophysiologists - J. Thomas Svinarich, MD, and Christopher Stees, DO - with the support of cardiac surgeon Jason Sperling, MD. The left atrial appendage (LAA) is accessed using minimally invasive techniques and a pre-tied suture loop is delivered. This seals off the LAA from the rest of the heart preventing blood clots that form in this area from traveling to the brain and causing a stroke. For patients at risk for stroke due to AFib, the non-invasive LARIAT™ procedure offers an alternative treatment for those unable to take blood thinning medications typically used to treat AFib.
“It is important to have a multidisciplinary approach to these procedures,” says Dr. Jason Sperling. “When the surgeon and electrophysiologist combine their efforts we have more to offer our patients.”
According to the American Heart Association® an estimated 2.7 million Americans are living with AFib. AFib is sometimes described as a quivering of the upper heart chambers (atria). Patients living with AFib are at risk for blood clots, stroke, heart failure and other heart-related complications. Untreated AFib causes a 4-5-fold increased risk for stroke, but many patients are unaware that AFib is a serious condition, according to the American Heart Association®.
About Rose Medical Center
Well known as a Denver institution and a 9th Avenue landmark for more than 60 years, Rose Medical Center has earned its reputation as Denver's "Baby Hospital" while becoming a leader in comprehensive women's, surgical and endoscopy services, heart and vascular, orthopedics, total joint replacement, bariatrics, and sports, internal and aesthetic medicine. With origins in Jewish teachings, traditions and community, Rose’s founders built this hospital to “serve the need of every creed.” By offering a high level of expertise and service across all disciplines, Rose has truly become a destination hospital, attracting patients from throughout Colorado and around the world. Learn more at www.rosemed.com. ###
We are committed to superior patient care. Our primary focus is and always has been you, the patient. Please explore our web site to find links to our locations, forms for you to download, information about your upcoming tests and procedures, and contact information for our scheduling and billing departments.
Colorado Heart and Vascular Echocardiography Laboratory Receives Echocardiography Accreditation by the IAC
Cardiovascular diseases are the No. 1 cause of death in the United States. On average, one American dies every 39 seconds of cardiovascular disease – disorders of the heart and blood vessels. The American Heart Association estimates that the direct and indirect cost for cardiovascular disease in the U.S. for 2010 was $503.2 billion.
"Mehta would like to see full disclosure of what’s in energy drinks. He’d also like to see regulation of how much caffeine they can contain. He urges parents to pay close attention to what their children are drinking."
WARFARIN Study at Colorado Heart & Vascular to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
To improve patient safety and reduce healthcare costs, Denver takes major role in first personalized medicine study authorized by Centers for Medicare & Medicaid Services